These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 24716456)

  • 1. Clinical trial designs in PAH: shifting from functional measurements to long-term clinical outcomes.
    Studer SM; Gilkin RJ
    Am J Manag Care; 2014 Mar; 20(6 Suppl):S115-22. PubMed ID: 24716456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.
    McLaughlin VV; Benza RL; Rubin LJ; Channick RN; Voswinckel R; Tapson VF; Robbins IM; Olschewski H; Rubenfire M; Seeger W
    J Am Coll Cardiol; 2010 May; 55(18):1915-22. PubMed ID: 20430262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early decline in six-minute walk distance from the time of diagnosis predicts clinical worsening in pulmonary arterial hypertension.
    Huang J; Mehta S; Mura M
    Respiration; 2015; 89(5):365-73. PubMed ID: 25791910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical worsening in trials of pulmonary arterial hypertension: results and implications.
    Galiè N; Simonneau G; Barst RJ; Badesch D; Rubin L
    Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S11-9. PubMed ID: 20375660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based pharmacologic management of pulmonary arterial hypertension.
    Benedict N; Seybert A; Mathier MA
    Clin Ther; 2007 Oct; 29(10):2134-53. PubMed ID: 18042471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The need to move from 6-minute walk distance to outcome trials in pulmonary arterial hypertension.
    Gaine S; Simonneau G
    Eur Respir Rev; 2013 Dec; 22(130):487-94. PubMed ID: 24293464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endpoints in pulmonary arterial hypertension: the role of clinical worsening.
    Peacock A; Keogh A; Humbert M
    Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S1-9. PubMed ID: 20375659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspective on the optimal endpoints for pulmonary arterial hypertension trials.
    Rubin L; Simonneau G
    Curr Opin Pulm Med; 2010 May; 16 Suppl 1():S43-6. PubMed ID: 20375664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy in the management of pulmonary arterial hypertension.
    Buckley MS; Staib RL; Wicks LM
    Int J Clin Pract Suppl; 2013 May; (179):13-23. PubMed ID: 23578069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of Clinical Trial Endpoints of Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension and How They Relate to Patient Outcomes in the United States.
    Divers C; Platt D; Wang E; Lin J; Lingohr-Smith M; Mathai SC
    J Manag Care Spec Pharm; 2017 Jan; 23(1):92-104. PubMed ID: 28025931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do changes of 6-minute walk distance predict clinical events in patients with pulmonary arterial hypertension? A meta-analysis of 22 randomized trials.
    Savarese G; Paolillo S; Costanzo P; D'Amore C; Cecere M; Losco T; Musella F; Gargiulo P; Marciano C; Perrone-Filardi P
    J Am Coll Cardiol; 2012 Sep; 60(13):1192-201. PubMed ID: 22995024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment goals of pulmonary hypertension.
    McLaughlin VV; Gaine SP; Howard LS; Leuchte HH; Mathier MA; Mehta S; Palazzini M; Park MH; Tapson VF; Sitbon O
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D73-81. PubMed ID: 24355644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. End-points and clinical trial design in pulmonary arterial hypertension: have we made progress?
    Peacock AJ; Naeije R; Galiè N; Rubin L
    Eur Respir J; 2009 Jul; 34(1):231-42. PubMed ID: 19567606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New perspectives in long-term outcomes in clinical trials of pulmonary arterial hypertension.
    Preston IR; Suissa S; Humbert M
    Eur Respir Rev; 2013 Dec; 22(130):495-502. PubMed ID: 24293465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliable and developmentally appropriate study end points are needed to achieve drug development for treatment of pediatric pulmonary arterial hypertension.
    Sun H; Stockbridge N; Ariagno RL; Murphy D; Nelson RM; Rodriguez W
    J Perinatol; 2016 Dec; 36(12):1029-1033. PubMed ID: 27416322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary arterial hypertension: progress and challenges in the modern treatment era.
    Mandras SA; Gilkin RJ; Pruett JA; Raspa S
    Am J Manag Care; 2014 Oct; 20(9 Suppl):S191-9. PubMed ID: 25495203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of oral treprostinil monotherapy for the treatment of pulmonary arterial hypertension: a randomized, controlled trial.
    Jing ZC; Parikh K; Pulido T; Jerjes-Sanchez C; White RJ; Allen R; Torbicki A; Xu KF; Yehle D; Laliberte K; Arneson C; Rubin LJ
    Circulation; 2013 Feb; 127(5):624-33. PubMed ID: 23307827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the predictive value of a clinical worsening definition using 2-year outcomes in patients with pulmonary arterial hypertension: a REVEAL Registry analysis.
    Frost AE; Badesch DB; Miller DP; Benza RL; Meltzer LA; McGoon MD
    Chest; 2013 Nov; 144(5):1521-1529. PubMed ID: 23907471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension.
    Galiè N; Seeger W; Naeije R; Simonneau G; Rubin LJ
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):81S-88S. PubMed ID: 15194183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrocardiographic Abnormalities and Their Association with Outcomes in Randomized Clinical Trials of Pulmonary Arterial Hypertension.
    Minhas J; Moutchia J; Al-Naamani N; Mazurek JA; Holmes JH; Appleby D; Smith KA; Fritz JS; Pugliese SC; Palevsky HI; Kawut SM
    Ann Am Thorac Soc; 2024 Jun; 21(6):858-865. PubMed ID: 38241602
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.